News

CPhI Launches First Part of Annual Report Ahead of Digital Expo

September 24, 2020

CPhI has launched the first part of its Annual Report.

Advanco and Syntegon Launch Strategic Serialization Partnership

September 24, 2020

A strategic serialization partnership has been announced by advanco and Syntegon, aimed at tackling the global issue of counterfeit drugs.

Telstar Reinforces Consultancy Service in Accordance with New Annex 1

September 24, 2020

Telstar has reinforced its consultancy service to aid pharmaceutical companies in the compliance of the latest version of the EU GMP Annex 1 guidance.

Catalent Acquires New Biologics Facility in Indiana

September 24, 2020

The facility for early-phase clinical biologics formulation development and drug product fill/finish services will be integrated with an existing Catalent facility nearby.

Evergreen Theragnostics Begins Construction of Manufacturing Facility

September 24, 2020

The radiopharmaceutical CDMO is building a new cGMP facility in Springfield, NJ.

Hovione and Ligand Partner to Increase Production of Captisol for Use in Remdesivir

September 23, 2020

The companies plan to increase the production output of Ligand’s Captisol for the formulation of Gilead’s COVID-19 treatment Veklury (remdesivir).

Piramal Pharma Solutions Opens Oral Solid Dosage Drug Product Facility

September 23, 2020

CMDO Piramal Pharma Solutions held a grand opening at a facility they acquired in Sellersville, PA.

Johnson & Johnson Launches Multi-Country Phase III Trial of Janssen’s COVID-19 Vaccine Candidate

September 23, 2020

A Phase III trial to evaluate safety and efficacy of Janssen’s COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S, is enrolling participants on three continents.

Thermo Fisher and Humanigen Partner for COVID-19 Therapeutic Candidate

September 23, 2020

Thermo Fisher will handle the technical transfer of the lenzilumab bulk drug substance process, with commercial scale production potentially beginning before the end of 2020.

Aphena Pharma Solutions Announces $21-Million Facility Expansion in Tennessee

September 23, 2020

The renovations are expected to be completed by Feb. 1, 2021 and, upon completion, Aphena will move its corporate headquarters to the new location.